19,063 Shares in Intuitive Surgical, Inc. $ISRG Acquired by ABN Amro Investment Solutions

ABN Amro Investment Solutions acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 19,063 shares of the medical equipment provider’s stock, valued at approximately $10,359,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in ISRG. Aaron Wealth Advisors LLC lifted its position in Intuitive Surgical by 0.8% during the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after buying an additional 19 shares in the last quarter. J. W. Coons Advisors LLC boosted its position in Intuitive Surgical by 1.4% during the first quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock valued at $741,000 after purchasing an additional 20 shares during the last quarter. Exencial Wealth Advisors LLC increased its holdings in Intuitive Surgical by 3.1% during the first quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider’s stock worth $327,000 after buying an additional 20 shares during the last quarter. Evergreen Capital Management LLC grew its holdings in Intuitive Surgical by 0.5% during the first quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock worth $2,124,000 after purchasing an additional 20 shares during the period. Finally, Rise Advisors LLC increased its position in Intuitive Surgical by 5.6% during the first quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after buying an additional 20 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Brian Edward Miller sold 3,500 shares of the business’s stock in a transaction on Monday, November 10th. The stock was sold at an average price of $575.00, for a total value of $2,012,500.00. Following the sale, the executive vice president directly owned 5,758 shares of the company’s stock, valued at approximately $3,310,850. The trade was a 37.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO David J. Rosa sold 24,500 shares of the stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. This trade represents a 9.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 101,683 shares of company stock worth $53,517,192 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on ISRG. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, October 31st. Leerink Partners raised their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Rothschild & Co Redburn lifted their target price on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Hsbc Global Res upgraded Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. Finally, Truist Financial set a $620.00 target price on Intuitive Surgical and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Intuitive Surgical Stock Up 0.0%

ISRG opened at $572.45 on Thursday. The stock has a market cap of $205.21 billion, a PE ratio of 75.72, a P/E/G ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The business’s fifty day simple moving average is $478.64 and its 200 day simple moving average is $502.49.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.84 EPS. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.